Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020

替加环素 鲍曼不动杆菌 肉汤微量稀释 粘菌素 美罗培南 抗菌剂 抗药性 头孢菌素 微生物学 抗生素 医学 抗生素耐药性 生物 最小抑制浓度 细菌 铜绿假单胞菌 遗传学
作者
Chih-Hao Chen,Pin-Han Wu,Min‐Chi Lu,Mao‐Wang Ho,Po‐Ren Hsueh
出处
期刊:International Journal of Antimicrobial Agents [Elsevier]
卷期号:61 (2): 106707-106707 被引量:18
标识
DOI:10.1016/j.ijantimicag.2022.106707
摘要

This study evaluated the in-vitro activity of multiple classes of antibiotics, including novel β-lactam combination agents, tigecycline and colistin, against carbapenem-resistant (CRAB), multi-drug-resistant (MDRAB) and difficult-to-treat (DTRAB) Acinetobacter baumannii. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution method. Susceptibility profiles and the distribution of selected antimicrobials among countries were illustrated and examined based on the breakpoints of the Clinical and Laboratory Standards Institute, European Committee on Antimicrobial Susceptibility Testing and the US Food and Drug Administration. In total, 847 A. baumannii isolates were evaluated, and 692 isolates were characterized as CRAB, MDRAB or DTRAB. The prevalence of drug-resistant A. baumannii was >70.0% in South Korea, India and China, while the resistance rate of tigecycline was <5.5%. The MICs of meropenem and meropenem/vaborbactam for drug-resistant A. baumannii were equal (both MIC50 and MIC90 were 32 mg/L, range 0.25-32 mg/L). The overall resistance rate remained high for multiple classes of antibiotics, including penicillins, cephalosporins, carbapenems, quinolones and aminoglycosides (>84.0%, >96.0%, >98.0%, >88.0% and >87.0%, respectively), but not colistin or tigecycline (1.1% and 4.3%, respectively). China showed the lowest susceptibility to tigecycline for drug-resistant A. baumannii isolates compared with other countries. In conclusion, the resistance rate of drug-resistant A. baumannii remains high against multiple classes of antimicrobials. Colistin was the most potent agent, followed by tigecycline. The geographic pattern of tigecycline-resistant A. baumannii varied among countries. Therefore, continuous surveillance of A. baumannii resistance profiles in different regions is required.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Sea_shark完成签到,获得积分10
刚刚
YY88687321完成签到 ,获得积分10
刚刚
1秒前
1秒前
默默海露发布了新的文献求助10
2秒前
lignin发布了新的文献求助10
2秒前
棋士应助Cloud采纳,获得10
2秒前
2秒前
蜀安应助笙箫采纳,获得30
2秒前
xiaoman发布了新的文献求助10
3秒前
sens完成签到,获得积分10
3秒前
是帆帆呀完成签到,获得积分10
3秒前
WZ发布了新的文献求助10
4秒前
A羊_发布了新的文献求助10
4秒前
5秒前
5秒前
JamesPei应助霸气剑通采纳,获得10
6秒前
merlinsong发布了新的文献求助10
7秒前
7秒前
8秒前
花花发布了新的文献求助10
8秒前
Walker完成签到,获得积分10
8秒前
华仔应助落寞的采文采纳,获得10
9秒前
青鱼发布了新的文献求助10
9秒前
lignin完成签到,获得积分10
9秒前
量子星尘发布了新的文献求助10
10秒前
TIANEO完成签到,获得积分20
10秒前
cytomix完成签到,获得积分10
10秒前
orixero应助年轻的冰淇淋采纳,获得10
10秒前
清新王老吉完成签到,获得积分10
11秒前
12秒前
12秒前
量子星尘发布了新的文献求助30
12秒前
默默海露完成签到,获得积分20
12秒前
Vicky1111完成签到,获得积分10
13秒前
13秒前
13秒前
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5718021
求助须知:如何正确求助?哪些是违规求助? 5250051
关于积分的说明 15284272
捐赠科研通 4868198
什么是DOI,文献DOI怎么找? 2614063
邀请新用户注册赠送积分活动 1563973
关于科研通互助平台的介绍 1521425